Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion
A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
15 drugs added to Medicare price negotiations
Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…
U.S. employer health plans tap prescriptions that feds say are illegal
Every step is a struggle for Bruce Zimmerman, whose health has been deteriorating since he was diagnosed with…
Eli Lilly, Merck, Gilead and AbbVie earnings preview
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday,…